Publikace
- Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2-and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma2016 | 1. lékařská fakulta, 2. lékařská fakulta
- Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo2016 | 1. lékařská fakulta
- Anti-Lymphoma Efficacy Comparison of Anti-CD20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates2015 | 1. lékařská fakulta
- Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research2014 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents2014 | 1. lékařská fakulta
- Roscovitin senzitizuje leukemické a lymfomové buňky na TRAIL2013 | Ústřední knihovna, 1. lékařská fakulta
- The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms2013 | Ústřední knihovna, 1. lékařská fakulta
- Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL)2013 | 1. lékařská fakulta
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma2023 | 1. lékařská fakulta, 3. lékařská fakulta
Loading network view...